Skip to main content
. 2020 Apr 30;11:591. doi: 10.3389/fphar.2020.00591

Figure 1.

Figure 1

Treatment response, amisulpride. Historical data from our group showing changes in PANSS positive symptoms in an independent cohort of 46 antipsychotic-naïve, first-episode schizophrenia patients treated with amisulpride (mean dose of 279.4 mg/day) monotherapy for six weeks. Details on the cohort have previously been published, e.g.(Nielsen et al., 2012a; Nielsen et al., 2012b; Nielsen et al., 2016; Wulff et al., 2019).